Lyka Labs Ltd.

BSE: 500259 | NSE: LYKALABS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE933A01014 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Lyka Labs Ltd. Lyka Labs Ltd. | BSE 83.10 0.00 (0.00%) | NSE 82.87 -0.62 (-0.74%) | Trade | Add

BSE Live

Nov 26, 16:00

83.10 0.00 (0.00%)

Volume

AVERAGE VOLUME

5-Day

3,954

10-Day

3,599

30-Day

2,412

9,451

Prev. Close

83.10
Open Price

84.68

Bid Price (Qty.)
83.10 (100)
Offer Price (Qty.)
85.00 (501)

NSE Live

Nov 26, 15:59

82.87 -0.62 (-0.74%)

Volume

AVERAGE VOLUME

5-Day

35,300

10-Day

47,615

30-Day

24,985

34,205

Prev. Close

83.49
Open Price

84.70

Bid Price (Qty.)
82.87 (90)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Lyka Labs (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	35.69	33.09	30.69	28.69	28.69
Total Share Capital	36.77	34.17	31.77	29.47	29.40
Reserves and Surplus	99.25	57.17	28.30	15.75	-24.28
Total Reserves and Surplus	99.25	57.17	28.30	15.75	-24.28
Total Shareholders Funds	136.03	100.41	77.50	45.22	5.12
NON-CURRENT LIABILITIES
Long Term Borrowings	18.12	41.83	62.33	60.85	150.35
Deferred Tax Liabilities [Net]	4.25	3.73	3.99	4.12	0.00
Other Long Term Liabilities	1.84	2.40	2.95	2.21	10.47
Long Term Provisions	0.56	1.74	2.13	2.44	2.68
Total Non-Current Liabilities	24.77	49.70	71.39	69.62	163.50
CURRENT LIABILITIES
Short Term Borrowings	18.72	13.66	7.64	66.59	10.09
Trade Payables	13.83	10.91	8.23	8.68	12.02
Other Current Liabilities	10.69	9.71	12.93	17.39	21.02
Short Term Provisions	1.54	1.49	1.17	1.02	1.62
Total Current Liabilities	44.78	35.78	29.97	93.68	44.75
Total Capital And Liabilities	205.58	185.88	178.86	208.51	213.37
ASSETS
NON-CURRENT ASSETS
Tangible Assets	76.89	45.80	47.31	67.18	66.59
Intangible Assets	7.55	9.84	18.22	22.94	28.75
Capital Work-In-Progress	0.20	21.97	15.10	16.23	16.18
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	85.64	78.70	81.75	107.86	119.73
Non-Current Investments	32.40	32.40	32.40	32.40	32.40
Deferred Tax Assets [Net]	0.00	0.00	0.00	0.00	16.22
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	21.42	24.92	22.41	20.34	19.28
Total Non-Current Assets	139.46	136.02	136.56	160.60	187.64
CURRENT ASSETS
Current Investments	0.02	0.02	0.01	0.01	0.01
Inventories	12.47	9.56	6.94	8.18	4.30
Trade Receivables	40.45	25.73	17.16	17.59	9.90
Cash And Cash Equivalents	1.32	5.89	8.70	15.38	6.53
Short Term Loans And Advances	1.92	2.24	5.61	0.04	0.06
OtherCurrentAssets	9.94	6.43	3.88	6.71	4.94
Total Current Assets	66.12	49.86	42.30	47.91	25.74
Total Assets	205.58	185.88	178.86	208.51	213.37
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	33.56	35.84	24.58	35.34	22.78
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	0.00
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	8.39	3.23	0.00	0.00	0.00
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	--
Other Earnings	34.05	36.88	--	--	--
BONUS DETAILS
Bonus Equity Share Capital	1.20	1.20	1.20	1.20	1.20
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	32.40	32.40	32.40	32.40	32.40
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	0.02	0.02	0.01	0.01	0.01